Variation in total cholesterol, triglycerides linked to Alzheimer’s disease risk
Jul 06, 2023
Those in the highest quintile of total cholesterol and triglycerides had increased risk for Alzheimer’s disease and Alzheimer’s-related dementias.
Studies show benefits of exercise for those living with dementia, other older adults
By
Max Bachmann
Jul 06, 2023
Regular physical exercise, such as resistance training, can prevent or delay the symptoms of Alzheimer’s disease, a new study has found.
AI-driven speech analysis firm working to diagnose Alzehimer’s, Huntington’s
By
Aaron Dorman
Jun 27, 2023
A speech analysis software company is using Voice AI to diagnose depression and anxiety, and diseases like Alzheimer’s and Huntington’s could be next.
New law implements training, exam requirements for assisted living employees
By
Lois A. Bowers
Jun 27, 2023
A new law in Texas requires managers and caregivers at assisted living communities serving people living with dementia to complete four hours of dementia-related training and pass an exam about dementia,...
Bladder cancer treatment may lower risk for Alzheimer’s and related dementias
Jun 12, 2023
A greater effect was seen for patients aged 70 years and older at time of bacillus Calmette-Guerin vaccination.
Sleep-disordered breathing linked to medial temporal lobe atrophy in seniors
Jun 02, 2023
Higher sleep apnea severity was related to lower medial temporal lobe subregion volumes in amyloid-positive, but not amyloid-negative, individuals.
Telemedicine increases access to care for assisted living residents with dementia: study
By
Kimberly Bonvissuto
May 30, 2023
Although racial/ethnic and socioeconomically disadvantaged populations were less likely to use telemedicine early in the COVID-19 pandemic, a new study finds that telemedicine offered a way for members...
Causal link ID’d for Alzheimer’s disease, generalized epilepsy
May 25, 2023
A genetic predisposition to Alzheimer’s also is linked to an increased risk of focal epilepsy with hippocampal sclerosis.
Allopurinol may cut risk for neurodegenerative diseases
May 19, 2023
Allopurinol linked to 13 to 34 percent lower risk for Parkinson disease, Alzheimer disease, ALS
Medicare spending would increase $2.0 to $5.1 billion with lecanemab
May 18, 2023
$2.0 to $5.1 billion would include lecanemab and ancillary costs; estimated annual per-patient coinsurance could reach $6,636